AstraZeneca PLC
OTC:AZNCF
AstraZeneca PLC
OTC:AZNCF
Price:
204.27
USD
1.72%
Market Cap:
$316.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AstraZeneca PLC
OTC:AZNCF
|
UK |
|
A
|
Adevinta ASA
OTC:ADEVF
|
NO |
|
A
|
Aceso Life Science Group Ltd
HKEX:474
|
HK |
|
Apollo Future Mobility Group Ltd
HKEX:860
|
HK |
|
D
|
Doosan Tesna Inc
KOSDAQ:131970
|
KR |
|
Vertoz Advertising Ltd
NSE:VERTOZ
|
IN |
|
P
|
Pan American Silver Corp
NYSE:PAAS
|
CA |
|
O
|
Osaka Steel Co Ltd
TSE:5449
|
JP |
|
B
|
Bluenord ASA
OSE:BNOR
|
NO |
Multiples-Based Value
The Multiples-Based Value of one
AZNCF
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 204.27 USD,
AstraZeneca PLC
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AZNCF Multiples-Based Value
LOCKED
Multiples Across Competitors
AZNCF Competitors Multiples
AstraZeneca PLC Competitors
AstraZeneca PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
AstraZeneca PLC
OTC:AZNCF
|
236.9B USD | 5.3 | 30.7 | 16.9 | 23.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 17 | 7.2 | 8.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
101.3B EUR | 2.7 | 15.4 | 8.3 | 10.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
